2021
DOI: 10.11591/ijra.v10i4.pp340-352
|View full text |Cite
|
Sign up to set email alerts
|

Low-cost SARS-CoV-2 vaccine homogenization system for Pfizer-BioNTech covid-19 vials

Abstract: <p>The current SARS-CoV-2 pandemic has been affecting all sectors worldwide, and efforts have been targeting the enhancement of people’s health and labour conditions of collaborators belonging to healthcare institutions. The recent vaccines emerging against covid-19 are seen as a solution to address the problem that has already killed up to two million people. The preparation of the Pfizer-BioNTech covid-19 vaccine requires a specific manipulation before its administration. A correct homogenization with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 22 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?